This article selection displays a sample of research that Elsevier publishes in its microbiology and medical journals, highlighting Elsevier's contribution to the efforts of battling the huge problem of antimicrobial resistance (AMR). Research within this selection supports SDGs 3 (good health and well-being), 6 (clean water and sanitation), 12 (responsible production and consumption) and 17 (partnerships for the goals).
Anti-infective drugs have had a key role in the contemporary world, contributing to dramatically decrease mortality rates caused by infectious diseases worldwide. Antimicrobial peptides (AMPs) are multifunctional effectors of the innate immune system of mucosal surfaces and present antimicrobial activity against a range of pathogenic viruses, bacteria, and fungi. However, the discovery and development of new antibacterial drugs is a crucial step to overcome the great challenge posed by the emergence of antibiotic resistance.